Advertisement
News
Subscribe to MDT Magazine News

Gene fuelled transporter causes breast cancer cells to self-destruct

February 27, 2011 9:35 pm | by EurekAlert | Comments

(Queen's University Belfast) Scientists at Queen's University Belfast have shown that they can deliver a gene directly into breast cancer cells causing them to self-destruct, using an innovative, minuscule gene transport system, according to research published Feb. 28 in the...

TOPICS:

University of Miami scientists track great hammerhead shark migration

February 27, 2011 8:34 pm | by EurekAlert | Comments

(University of Miami Rosenstiel School of Marine & Atmospheric Science) A study led by Neil Hammerschlag at the University of Miami details the first scientific research to successfully track a great hammerhead shark using satellite tag technology.

TOPICS:

Life Technologies Launches Asia Distribution Center in Singapore

February 27, 2011 8:33 pm | by Bio-Medicine.Org | Comments

SINGAPORE, Feb. 28, 2011 /- US-based Life Technologies Corporation (Nasdaq: LIFE ), a provider of innovative life science solutions, announced today that it has launched a regional distribution hub in Singapore to address strong customer demand in the Asia Pacific regions of India, China,...

TOPICS:
Advertisement

Fish oil fights weight loss due to chemotherapy

February 27, 2011 8:32 pm | by EurekAlert | Comments

(Wiley-Blackwell) A new analysis has found that supplementing the diet with fish oil may prevent muscle and weight loss that commonly occurs in cancer patients who undergo chemotherapy. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the study...

TOPICS:

One-Cubic-Millimeter Computer

February 27, 2011 7:36 pm | by Massachusetts Institute of Technology | Comments

A prototype sensor consumes just a few nanowatts and could take glucose readings from the eye.

A Pacemaker the Size of a Tic Tac

February 27, 2011 7:34 pm | by Massachusetts Institute of Technology | Comments

Medtronic is using microelectronics to make a pacemaker so small it can be injected.

TOPICS:

Canada's role grows amid looming world water shortages in some places, more flooding in others

February 27, 2011 10:34 am | by EurekAlert | Comments

(Canadian Water Network) With a view to UN World Water Day, March 22, experts convening in Ottawa Feb. 28 to March 3 say water-rich Canada and water management experts have growing importance as countries elsewhere brace for more frequent drought, flood and unsafe water problems...

TOPICS:

Adeona Mourns the Passing of David A. Newsome, M.D., Senior Vice President of Research & Development

February 27, 2011 1:35 am | by Bio-Medicine.Org | Comments

ANN ARBOR, Mich., Feb. 27, 2011 /- With deep regret, Adeona Pharmaceuticals, Inc. (Amex: AEN ), announced today the passing of its Senior Vice President of Research & Development, David A. Newsome, M.D. Dr. Newsome invented and developed ZincMonoCysteine and was the first person to...

TOPICS:
Advertisement

FDA Grants Full Approval for PROMACTA® (eltrombopag) for Treatment of Rare Blood Disorder

February 25, 2011 10:36 pm | by Bio-Medicine.Org | Comments

PHILADELPHIA, Feb. 25, 2011 /- GlaxoSmithKline (NYSE: GSK ) today announced that the United States Food and Drug Administration (FDA) granted full approval for PROMACTA® (eltrombopag), an oral tablet that can raise platelet counts in patients with the rare blood disorder chronic...

TOPICS:

Radio-guided surgery a safe and simple way to remove potentially cancerous nodules in the lung

February 25, 2011 10:33 pm | by EurekAlert | Comments

(European Society for Medical Oncology) Using tiny spheres of radioactive liquid to guide surgeons as they remove potentially cancerous material in the lungs is safe and more effective than other techniques, Italian researchers report.

TOPICS:

Erlotinib effective and with fewer side-effects after first-line treatment

February 25, 2011 10:33 pm | by EurekAlert | Comments

(European Society for Medical Oncology) The targeted cancer drug erlotinib has comparable efficacy to chemotherapy, and is better tolerated, in hard-to-treat cases where a patient's cancer has progressed quickly after treatment with first-line therapy, the results of a new phase III trial show.

TOPICS:

Oxford Instruments and ITRI jointly establish research center for WLP and LED packaging development

February 25, 2011 5:37 pm | by I-Micronews | Comments

Oxford Instruments and Industry Technology Research Institute (ITRI) have jointly set up a research center for wafer-level packaging (WLP) process in high-brightness LED and micro structure technology.

Direct Grid Technologies micro-inverter in volume production

February 25, 2011 5:36 pm | by I-Micronews | Comments

After a rigorous and demanding beta and pilot production period, Direct Grid is now shipping its DGM‐460 micro inverter in volume for lead customers in North America.

Defense Department awards Tricare deal to Humana(2)

February 25, 2011 3:47 pm | by The Associated Press | Comments

Humana will continue providing health care to military members and their families in the South.The company announced Friday that the Department of Defense re-evaluated an earlier decision to award the contract for Tricare health coverage to UnitedHealth. A congressional agency supported...

Defense Department awards Tricare deal to Humana

February 25, 2011 3:46 pm | Comments

Humana will continue providing health care to military members and their families in the South.The company announced Friday that the Department of Defense re-evaluated an earlier decision to award the contract for Tricare health coverage to UnitedHealth. A congressional agency supported...

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading